ENTA Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Company uses its chemistry-driven approach & drug discovery capabilities to develop its products.

$82.72  -1.46 (-1.73%)
As of 12/03/2021 15:59:48 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2013
Outstanding shares:  20,324,795
Average volume:  256,117
Market cap:   $1,710,941,243
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29251M106
ISIN:        US29251M1062
Sedol:      B9L5200
Valuation   (See tab for details)
PE ratio:   -21.27
PB ratio:   4.19
PS ratio:   17.63
Return on equity:   -19.78%
Net income %:   -81.38%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy